These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8305260)

  • 1. [Non-steroid anti-inflammatory agents and digestive tract lesions].
    Lanas Arbeloa AI; Hirschowitz BI
    Rev Esp Enferm Dig; 1993 Nov; 84(5):326-35. PubMed ID: 8305260
    [No Abstract]   [Full Text] [Related]  

  • 2. [NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
    MMW Fortschr Med; 2010 May; 152(20):46-7. PubMed ID: 20552882
    [No Abstract]   [Full Text] [Related]  

  • 3. The epidemiology of NSAID associated gastrointestinal disease.
    Wolfe F
    Eur J Rheumatol Inflamm; 1991; 11(3):12-28. PubMed ID: 1365476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency and severity of gastric and duodenal lesions induced by non-steroidal anti-inflammatory agents and aspirin].
    Florent C; Desaint B
    Gastroenterol Clin Biol; 1989 Mar; 13(3):235-8. PubMed ID: 2731675
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective COX-2 inhibitors: a promise unfulfilled?
    Henry D; McGettigan P
    Gastroenterology; 2007 Feb; 132(2):790-4. PubMed ID: 17261306
    [No Abstract]   [Full Text] [Related]  

  • 6. Major gastrointestinal ulceration in association with Piroxicam therapy.
    Irving AD; Sadek SA
    J R Coll Surg Edinb; 1983 Mar; 28(2):121-2. PubMed ID: 6602880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Non-steroidal anti-inflammatory agents and digestive lesions].
    Bellanger J; Pointereau-Bellanger A
    Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):237-48. PubMed ID: 2694919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of non-steroidal anti-inflammatory agents on the upper gastro-intestinal tract: gastroscopic findings in Nigerians.
    Atoba MA; Olubuyide IO
    Cent Afr J Med; 1989 Jul; 35(7):427-30. PubMed ID: 2582486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract.
    Barrier CH; Hirschowitz BI
    Arthritis Rheum; 1989 Jul; 32(7):926-32. PubMed ID: 2787642
    [No Abstract]   [Full Text] [Related]  

  • 11. Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?
    Langman MJ
    Pharmacoepidemiol Drug Saf; 2001; 10(1):13-9. PubMed ID: 11417061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal complications of nonsteroidal anti-inflammatory drugs.
    Babb RR
    West J Med; 1992 Oct; 157(4):444-7. PubMed ID: 1462539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between age and NSAID.
    Woodroof GM
    J R Nav Med Serv; 1986; 72(3):181-2. PubMed ID: 3668896
    [No Abstract]   [Full Text] [Related]  

  • 14. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Legido J; García-Sanz I; Pajares JM
    Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
    Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-inflammatory drugs and gastrointestinal lesions, or vice versa].
    Mearin F
    Med Clin (Barc); 1992 Mar; 98(11):413-5. PubMed ID: 1569792
    [No Abstract]   [Full Text] [Related]  

  • 17. [Can gastroduodenal lesions induced by non-steroidal anti-inflammatory agents be prevented?].
    Florent C; Florent M; Desaint B
    Rev Med Suisse Romande; 1992 Jun; 112(6):497-500. PubMed ID: 1631460
    [No Abstract]   [Full Text] [Related]  

  • 18. Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer.
    Christensen S; Riis A; Nørgaard M; Thomsen RW; Sørensen HT
    Aliment Pharmacol Ther; 2007 Apr; 25(8):907-12. PubMed ID: 17402994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New antirheumatism agents in old stomachs].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1986 Oct; 130(41):1827-9. PubMed ID: 3491330
    [No Abstract]   [Full Text] [Related]  

  • 20. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Singh G; Fries JF
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.